🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This purpose of this study is to test if talazoparib is safe and evaluate i...
Status
Withdrawn
Location
Stanford University
Start Date
2023-02-23
Trial ID
NCT04756765
Treatments Being Tested
This phase Ib trial is to find out the best dose, possible benefits and/or ...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-12-01
Trial ID
NCT04693468
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of talazoparib...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2020-10-23
Trial ID
NCT04207190
This phase I trial investigates the side effects and best dose of talazopar...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2021-06-08
Trial ID
NCT04511039
Treatments Being Tested
To learn about the effectiveness of adding talazoparib to the standard of c...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2025-06-03
Trial ID
NCT05873192
Treatments Being Tested
The aim of this single-arm phase 2 clinical trial is to evaluate the anti-c...
Status
Completed
Location
Stanford Medicine at Stanford University
Start Date
2015-08
Trial ID
NCT02401347
Treatments Being Tested
This phase II LUNG-MAP treatment trial studies how well combination treatme...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2020-02-14
Trial ID
NCT04173507
Treatments Being Tested